Cell Therapeutics, Inc. (NASDAQ:CTIC)
The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
liken22
(< 20)
Submitted: 1/30/2012 10:59:47 AM :
Start Price:
$1.08
CTIC Score:
-4.25
Hit the lowest cap in a long time, so I think will go up
Recs
tommywaaf
(< 20)
Submitted: 1/26/2012 5:14:28 PM :
Start Price:
$1.35
CTIC Score:
-23.58
Euro possible apporval in mid feb. Could bring interest
Recs
Quaker08
(99.08)
Submitted: 6/30/2011 2:31:48 PM :
Start Price:
$2.14
CTIC Score:
+52.28
This has to be one of the worst investments in America. Expect more share dilution and FDA rejections. I don't think they will ever turn a profit or get a drug to market.
Recs
ltgenspecific
(< 20)
Submitted: 6/14/2010 5:44:12 PM :
Start Price:
$2.99
CTIC Score:
-68.95
going with the gut, something's bound to give, Pixuvri seems to be somewhat effective... risky but if it takes, it'll run
Recs
libertybrewcity
(< 20)
Submitted: 9/3/2009 12:59:57 AM :
Start Price:
$9.18
CTIC Score:
-123.42
The new drug is about to go into phase 3 and the stock will explode!
Recs
dbbfool63
(76.53)
Submitted: 8/27/2009 6:28:48 PM :
Start Price:
$9.54
CTIC Score:
-118.89
Good entry point for mid to long term.
I couldn't get in until it got above a dollar to rate it although been watching since .o7/shr.
Probably could of got in lower, but lost track watching others.
Recs
aikiboy2k
(47.17)
Submitted: 8/26/2009 1:23:37 PM :
Start Price:
$9.60
CTIC Score:
-120.68
New cancer drug looks like it will be accepted by FDA.
Recs
notehound
(< 20)
Submitted: 8/24/2009 2:41:51 PM :
Start Price:
$9.90
CTIC Score:
-120.91
A pipeline of drugs in advanced trials with promising efficacy results, paring of debt, a recent $30 million infusion of cash - and they've been around since 1991.
I figure they ain't going to -0-.
Recs
Brian7992
(< 20)
Submitted: 8/20/2009 7:40:30 AM :
Start Price:
$10.08
CTIC Score:
-124.86
Best Bio Bets
Recs
STERLINGACTERRA
(< 20)
Submitted: 8/6/2009 1:31:28 PM :
Start Price:
$9.18
CTIC Score:
-124.41
I HAVE BEEN FOLLOWING CTIC FOR ABOUT 6 MONTHS NOW...HAVE CASHED OUT ON PROFITS ONCE SO FAR AND WILL AGAIN VERY SOON. TOOK PART IN THE PHONE UPDATE THIS MORNING AND BOUGHT ANOTHER BLOCK OF STOCKS...I'M A STRONG BELIEVER THAT THIS STOCK WILL SOON TAKE OFF.
FDA WILL DECIDE ABOUT FAST TRACK LATER THIS MONTH...SHOULD SEE A JUMP IN STOCK STRENGTH IN THE WEEK LEADING UP TO THE ANNOUNCEMENT THEN ANOTHER JUMP IF CTIC RECEIVES A FAVORABLE DECISSION. DECEMBER 24TH WILL THEN BRING A VERY HAPPY HOLIDAY TO THE SHAREHOLDERS. LET IT BE WRITTEN ...LET IT BE DONE!
Recs
janineboulayseib
(21.03)
Submitted: 8/5/2009 9:22:40 AM :
Start Price:
$9.36
CTIC Score:
-124.34
Pussing several promissing drugs to market, plenty of cash on hand, look at the price, cant go anywhere but up......
Recs
AVTX
(< 20)
Submitted: 7/21/2009 2:50:59 AM :
Start Price:
$9.24
CTIC Score:
-139.44
The National Cancer Institute presented on July 20 a new preclinical research identifying unique anti-tumor mechanisms of brostallicin that sets this agent apart from other currently used chemotherapy agents. CTI acquired worldwide rights to brostallicin when it acquired privately-held Systems Medicine LLC in 2007. This stock should be going up at no time.
read to full report:
http://finance.yahoo.com/news/National-Cancer-Institute-prnews-2409163949.html?x=0&.v=1
Recs
garrick1
(< 20)
Submitted: 7/5/2009 5:05:55 PM :
Start Price:
$9.00
CTIC Score:
-140.60
3 major new cancer fighting drugs just had successful trials and should roll out over the next few months, conservatively doubling the stock price by year's end.
Recs
LinuxCentOS
(41.50)
Submitted: 6/30/2009 6:23:35 PM :
Start Price:
$10.32
CTIC Score:
-136.43
Drugs in pipeline.
Recs
mjspillman
(< 20)
Submitted: 6/25/2009 3:13:43 PM :
Start Price:
$9.30
CTIC Score:
-136.28
Their products are unique and effective within the biotech industry.
Recs
stockcousin
(< 20)
Submitted: 6/25/2009 2:33:52 PM :
Start Price:
$9.18
CTIC Score:
-136.61
I believe that Cell Therapeutic's new drug, Pixantrone will help this company go over the top. They've recently submitted it to the FDA and if it goes thru, the stock prices could really climb.
Recs
igotsmoney
(< 20)
Submitted: 6/19/2009 3:41:28 PM :
Start Price:
$9.12
CTIC Score:
-137.06
cti has 2 phase IIII cancer treatment drugs pixantrone & opaxio and another drug in phase III brostallicin. I think this stock will skyrocket very soon.
Recs
PugMaster007
(< 20)
Submitted: 6/9/2009 5:13:52 PM :
Start Price:
$9.90
CTIC Score:
-132.03
New drug to hit the market soon.
Recs
hldhstg
(< 20)
Submitted: 6/4/2009 9:24:30 PM :
Start Price:
$10.50
CTIC Score:
-132.59
Sixth Sense?
Recs
flexd5g
(< 20)
Submitted: 6/4/2009 6:13:36 PM :
Start Price:
$10.50
CTIC Score:
-132.59
Will gain substantially when Pix is submitted for approval, sometime within the next month or so. Then the next big jump will come upon approval by the FDA, if given priority review, by the end of the year. Great buy now, hold for 5 months, then strong buy again. very sttrong pipeline for future company growth and eliminating debt faster than expected.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 44 : 1 2 3 Next »